Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has relapsed may benefit from adding antibody treatment to usual chemotherapy, according to new results from a clinical trial. Read more: https://www.birmingham.ac.uk/news/2025/adding-antibody-treatment-to-chemo-boosts-outcomes-for-children-with-rare-cancer

Removing etoposide from frontline induction chemotherapy did not appear to negatively affect key outcomes for patients with pediatric acute myeloid leukemia (AML), according to recent findings from a Children’s Oncology Group (COG) clinical trial presented at the ASH Annual Meeting 2025. Read more: https://www.cancertherapyadvisor.com/reports/etoposide-safely-eliminated-pediatric-acute-myeloid-leukemia/

Our SIOPEL-6 study showed that sodium thiosulfate (Pedmarqsi) almost halves the percentage of children and teenagers who lose hearing as...

“One thing we can do to really help patients with cancer is to make chemotherapy safer without reducing its effectiveness. I believe this...

Scientists at St. Jude Children’s Research Hospital have discovered non-coding genetic variants contributing to chemotherapy resistance...

The link is not uncommon: ‘Cardiotoxicity’ is a major side effect of anticancer treatments. Read more: https://www.washingtonpost.com/wel...

An additional dose of palonosetron can help prevent chemotherapy-induced nausea and vomiting (CINV) in children with cancer who are...

A new study, which is to be presented to the RNID Hearing Therapeutics Summit, found that a drug called Pedmark, also known as ...

In a new study, scientists from the Princess Máxima Center investigated the risk of breast cancer in women who were treated for childhood...

A common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washington ...